Intervene with JAKAFI XR

Explore the data through expert perspectives

POLYCYTHEMIA VERA

For treatment of PV in adults who have had an inadequate response to or are intolerant of hydroxyurea

Hana Safah, MD

MPN Expert

Hana Safah, MD, MPN Expert
MYELOFIBROSIS

For treatment of intermediate- or high-risk MF, including primary MF, post–polycythemia vera MF, and post–essential thrombocythemia MF in adults

Jamie Koprivnikar, MD

MPN Expert

Jamie Koprivnikar, MD, MPN Expert
CHRONIC GRAFT-VERSUS-HOST DISEASE

For treatment of cGVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older

Haris Ali, MD

GVHD Expert

Haris Ali, MD, GVHD Expert
ACUTE GRAFT-VERSUS-HOST DISEASE

For treatment of steroid-refractory aGVHD in adult and pediatric patients 12 years and older

Michael Bishop, MD

GVHD Expert

Michael Bishop, MD, GVHD Expert

MPN=myeloproliferative neoplasm.

POLYCYTHEMIA VERA
Hana Safah, MD, MPN Expert

For treatment of PV in adults who have had an...

Hana Safah, MD

MPN Expert

MYELOFIBROSIS
Jamie Koprivnikar, MD, MPN Expert

For treatment of intermediate- or high-risk MF, including...

Jamie Koprivnikar, MD

MPN Expert

CHRONIC GRAFT-VERSUS-HOST DISEASE
Haris Ali, MD, GVHD Expert

For treatment of cGVHD after failure of one or two lines of...

Haris Ali, MD

GVHD Expert

ACUTE GRAFT-VERSUS-HOST DISEASE
Michael Bishop, MD, GVHD Expert

For treatment of steroid-refractory aGVHD in adult and...

Michael Bishop, MD

GVHD Expert

MPN=myeloproliferative neoplasm.